Fengdi H. Li
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Comparison of the pathogenicity of multiple SARS-CoV-2 variants in mouse models.
Journal: Animal models and experimental medicine
Published: January 23, 2025
ILC3 Function as a Double-Edged Sword in EV71 Infection.
Journal: Viruses
Published: December 18, 2024
Single-cell spatiotemporal analysis reveals alveolar dendritic cell-T cell immunity hubs defending against pulmonary infection.
Journal: Cell discovery
Published: June 25, 2024
Single-cell spatiotemporal analysis of the lungs reveals Slamf9+ macrophages involved in viral clearance and inflammation resolution.
Journal: Cell discovery
Published: June 25, 2024
IL-37 Mitigates the Inflammatory Response in Macrophages Induced by SARS-CoV-2 Omicron Infection Through the NF-κB Signaling Pathway.
Journal: MedComm
Published: June 25, 2024
Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumonia.
Journal: Protein & cell
Published: April 19, 2024
IL-37 possesses both anti-inflammatory and antiviral effects against Middle East respiratory syndrome coronavirus infection.
Journal: Animal models and experimental medicine
Published: March 20, 2024
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5.
Journal: Signal transduction and targeted therapy
Published: January 22, 2024
Infection with SARS-CoV-2 can cause pancreatic impairment.
Journal: Signal transduction and targeted therapy
Published: October 21, 2023
Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 24, 2023
Comparison of the replication and neutralization of different SARS-CoV-2 Omicron subvariants in vitro.
Journal: Animal models and experimental medicine
Published: October 26, 2022
H1N1 influenza virus dose dependent induction of dysregulated innate immune responses and STAT1/3 activation are associated with pulmonary immunopathological damage.
Journal: Virulence
Published: September 09, 2022
Last Updated: 09/26/2026